decisionhealth Newsletters, Coder Pink Sheets - 2014 Issue 10 (October)
Watch for drops in prices of commonly billed drugs in Q4 ASP pricing
Subscribe or sign in to view the full article.
Article Overview
This premium article explains a quarterly Medicare Part B drug pricing update with a focus on commonly billed injectable drugs and influenza vaccines. It is useful for coders, billers, revenue cycle staff, and compliance teams who monitor ASP-based payment changes and related CMS pricing updates.
Why This Topic Matters
Quarterly ASP updates can affect reimbursement, charge capture, and budgeting for high-volume drugs and vaccines. The article helps readers understand which commonly billed products changed in price and where CMS added or finalized flu vaccine pricing.
Article Sections
-
Drug billing
Overview of the ASP pricing update and a summary of price changes affecting commonly billed Part B drugs.
-
Small percentage, big price change
Discussion of selected drugs where relatively small percentage shifts still matter because of utilization or baseline price levels.
-
4 flu vaccine prices added
Update on influenza vaccine pricing for the season and related CMS pricing context.
What You Will Learn
- How quarterly ASP pricing updates can affect commonly billed drugs
- Which broad categories of drugs experienced notable price movement
- How influenza vaccine pricing updates are reflected in the ASP file
- Why utilization can make small price changes financially significant
Who Should Read This
- Medical coders
- Medical billers
- Revenue cycle staff
- Compliance professionals
- Practice managers
- Healthcare finance teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com